Authors:
ECONOMOUPETERSEN E
AESSOPOS A
KLADI A
FLEVARI P
KARABATSOS F
FRAGODIMITRI C
NICOLAIDIS P
VRETTOU H
VASSILOPOULOS D
KARAGIORGALAGANA M
KREMASTINOS DT
PETERSEN MB
Citation: E. Economoupetersen et al., APOLIPOPROTEIN-E EPSILON-4 ALLELE AS A GENETIC RISK FACTOR FOR LEFT-VENTRICULAR FAILURE IN HOMOZYGOUS BETA-THALASSEMIA, Blood, 92(9), 1998, pp. 3455-3459
Authors:
HADZIYANNIS SJ
SPANOU E
HADZIYANNIS AS
TRIANTAFILLIDIS E
VRETTOU H
PAPAKONSTANTINOU A
GIOUSTOZI A
Citation: Sj. Hadziyannis et al., G GBV-C INFECTION IN THE GENERAL-POPULATION AND IN HIGH-RISK GROUPS OF A EUROPEAN COUNTRY/, Hepatology, 26(4), 1997, pp. 790-790
Authors:
POLITIS C
FRAGATOU S
VRETTOU H
HATZILAOU J
TZIOKA A
MIARITI N
XANTHAKI A
BASSAYIANNIS A
Citation: C. Politis et al., HUMAN RECOMBINANT ERYTHROPOIETIN USED ALO NE AND IN COMBINATION WITH HYDROXYUREA IN THALASSEMIA-INTERMEDIA AND SICKLE-CELL DISEASE PATIENTS, Gematologia i transfuziologia, 42(1), 1997, pp. 15-16
Authors:
HADZIYANNIS SJ
PAPAKONSTANTINOU A
VRETTOU H
SPANOU F
ZACHARAKIS G
LARAS A
Citation: Sj. Hadziyannis et al., FREQUENCY AND CLINICAL CORRELATES OF DUAL INFECTIONS WITH THE HEPATITIS-G AND HEPATITIS-C VIRUSES, Hepatology, 24(4), 1996, pp. 410-410
Authors:
RAPTOPOULOUGIGI M
SPAIA S
GARIFALLOS A
XENOU P
ORPHANOU H
ZARAFIDOU E
PETRIDOU P
VRETTOU H
VAGIONAS G
GALAKTIDOU G
MAVROUDI I
EFKARPIDOU A
KORTSARIS A
Citation: M. Raptopoulougigi et al., INTERFERON-ALPHA-2B TREATMENT OF CHRONIC HEPATITIS-C IN HEMODIALYSIS-PATIENTS, Nephrology, dialysis, transplantation, 10(10), 1995, pp. 1834-1837
Authors:
HESS G
HORSCH A
HADZIYANNIS S
VRETTOU H
WAGES J
PIATAK M
KIM JP
FOUNG S
KARAYINNIS P
THOMAS HC
Citation: G. Hess et al., THE PREVALENCE OF A NEW HEPATITIS-VIRUS (HGV) IN PATIENTS WITH LIVER-DISEASE AND IN GROUPS AT HIGH-RISK OF EXPOSURE TO BLOOD AND BLOOD PRODUCTS, Transfusion, 35(10), 1995, pp. 224-224
Authors:
RAPTOPOULOU M
ORPHANOU H
VRETTOU H
AKRIBIADIS E
CHADZIKONSTANTINOU L
GOULIS G
Citation: M. Raptopoulou et al., INTERFERON TREATMENT OF CHRONIC ACTIVE HEPATITIS-B - EFFECT OF A 6-MONTH TREATMENT REGIMEN, Gut, 34(2), 1993, pp. 102-103